FDA Inspection 1112164 — Rohto-Mentholatum (Vietnam) Co., Ltd.
The FDA completed an inspection of Rohto-Mentholatum (Vietnam) Co., Ltd. on November 1, 2019 in Ho Chi Minh. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 1, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ho Chi Minh (Vietnam)